Canada markets closed

StageZero Life Sciences Ltd. (SZLS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.7200+0.0100 (+1.41%)
At close: 3:59PM EDT
Full screen
Previous Close0.7100
Open0.7100
Bid0.7200 x N/A
Ask0.7300 x N/A
Day's Range0.7100 - 0.7400
52 Week Range0.4000 - 1.6500
Volume315,216
Avg. Volume862,756
Market Cap43.716M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)-0.1920
Earnings DateApr. 05, 2019 - Apr. 08, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
  • ACCESSWIRE

    Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

    LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience.The Planet MicroCap Showcase: VIRTUAL begins on Tuesday, April 20, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders on current hot themes, including: SPACs, Cryptocurrency, Digital Assets, Cannabis, Psychedelics, and of course, Small-, Micro- and Nano-Cap investing.

  • ACCESSWIRE

    StageZero Life Sciences to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22, 2021

    TORONTO, ON / ACCESSWIRE / April 19, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to early detection of multiple disease states through whole blood, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22 at 8:30 AM EST. James Howard-Tripp, Chairman and CEO of StageZero will be hosting the presentation and answering questions from investors.

  • ACCESSWIRE

    StageZero Life Sciences Introduces Aristotle, The First Multi-Cancer Test From A Single Sample of Blood

    TORONTO, ON / ACCESSWIRE / April 5, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") on Thursday April 1st, announced it was partnering with Health Clinics and Care Oncology to launch the early cancer diagnostic program AVRT centered around Aristotle, StageZero's multi-cancer test.The Aristotle Female panel is 9 tests for cancer: ovarian, breast, cervical, endometrial, colorectal, bladder, stomach, liver and nasopharyngeal.